Caspofungin-induced severe toxic epidermal necrolysis

Ming Chia Lee, Ya Wen Ni, Chun Hua Wang, Chih Hsin Lee, Ta Wei Wu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

OBJECTIVE: To report a case of suspected caspofungin-induced toxic epidermal necrolysis (TEN). CASE SUMMARY: An 86-year-old man had a right femur intertrochanteric fracture and right proximal humerus fracture due to an accidental fall. Disseminated Candida krusei infection complicated the postoperative course. Candidemia persisted despite 25 days of treatment with parenteral fluconazole. The antifungal agent was changed to intravenous caspofungin. Immediately after administration of a caspofungin 70-mg loading dose, a transient skin rash developed, which resolved after discontinuation of the drug and immediate treatment with intravenous diphenhydramine 30 mg and methylprednisolone 40 mg. Six days later, a caspofungin 70-mg loading dose was given again due to increasing sepsis. Erythematous and purpuric macules and plaques developed the next day and rapidly progressed to extensive erythema, exfoliation, blisters, and skin erosions. A dermatologist was consulted and TEN was diagnosed. The patient was treated with intravenous hydrocortisone 100 mg every 8 hours and diphenhydramine 30 mg every 8 hours. The skin lesions progressed unrelentingly and the patient died of refractory shock 6 days later. DISCUSSION: TEN is a rare but life-threatening systemic and cutaneous disease that is most often the result of an adverse drug reaction. It usually manifests as fever and influenza-like symptoms 1-3 days before the development of mucocutaneous lesions, namely erythema and erosions of the buccal, ocular, and genital mucosa and characteristic epidermal detachment. The precise pathogenesis is not fully understood. Several models have been described, including immunopathology, genetic susceptibility, Fas-Fas ligand, perforin/granzyme, and cytokine dysregulation. Use of the Naranjo probability scale indicated a probable relationship between caspofungin and the development of TEN in this patient. CONCLUSIONS: This is the first report of caspofungin-induced TEN. Health-care professionals are advised to be aware of the early presentations of TEN in patients receiving caspofungin.

Original languageEnglish
Pages (from-to)1116-1118
Number of pages3
JournalAnnals of Pharmacotherapy
Volume44
Issue number6
DOIs
Publication statusPublished - Jun 2010
Externally publishedYes

Fingerprint

caspofungin
Stevens-Johnson Syndrome
Diphenhydramine
Erythema
Accidental Falls
Candidemia
Granzymes
Perforin
Skin
Fas Ligand Protein
Cheek
Fluconazole
Antifungal Agents
Humerus
Methylprednisolone
Hip Fractures
Blister
Genetic Predisposition to Disease
Exanthema
Drug-Related Side Effects and Adverse Reactions

Keywords

  • Adverse drug event
  • Caspofungin
  • Toxic epidermal necrolysis

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Caspofungin-induced severe toxic epidermal necrolysis. / Lee, Ming Chia; Ni, Ya Wen; Wang, Chun Hua; Lee, Chih Hsin; Wu, Ta Wei.

In: Annals of Pharmacotherapy, Vol. 44, No. 6, 06.2010, p. 1116-1118.

Research output: Contribution to journalArticle

Lee, Ming Chia ; Ni, Ya Wen ; Wang, Chun Hua ; Lee, Chih Hsin ; Wu, Ta Wei. / Caspofungin-induced severe toxic epidermal necrolysis. In: Annals of Pharmacotherapy. 2010 ; Vol. 44, No. 6. pp. 1116-1118.
@article{0d9c59b4501d4df3bd5d941bf5f7de17,
title = "Caspofungin-induced severe toxic epidermal necrolysis",
abstract = "OBJECTIVE: To report a case of suspected caspofungin-induced toxic epidermal necrolysis (TEN). CASE SUMMARY: An 86-year-old man had a right femur intertrochanteric fracture and right proximal humerus fracture due to an accidental fall. Disseminated Candida krusei infection complicated the postoperative course. Candidemia persisted despite 25 days of treatment with parenteral fluconazole. The antifungal agent was changed to intravenous caspofungin. Immediately after administration of a caspofungin 70-mg loading dose, a transient skin rash developed, which resolved after discontinuation of the drug and immediate treatment with intravenous diphenhydramine 30 mg and methylprednisolone 40 mg. Six days later, a caspofungin 70-mg loading dose was given again due to increasing sepsis. Erythematous and purpuric macules and plaques developed the next day and rapidly progressed to extensive erythema, exfoliation, blisters, and skin erosions. A dermatologist was consulted and TEN was diagnosed. The patient was treated with intravenous hydrocortisone 100 mg every 8 hours and diphenhydramine 30 mg every 8 hours. The skin lesions progressed unrelentingly and the patient died of refractory shock 6 days later. DISCUSSION: TEN is a rare but life-threatening systemic and cutaneous disease that is most often the result of an adverse drug reaction. It usually manifests as fever and influenza-like symptoms 1-3 days before the development of mucocutaneous lesions, namely erythema and erosions of the buccal, ocular, and genital mucosa and characteristic epidermal detachment. The precise pathogenesis is not fully understood. Several models have been described, including immunopathology, genetic susceptibility, Fas-Fas ligand, perforin/granzyme, and cytokine dysregulation. Use of the Naranjo probability scale indicated a probable relationship between caspofungin and the development of TEN in this patient. CONCLUSIONS: This is the first report of caspofungin-induced TEN. Health-care professionals are advised to be aware of the early presentations of TEN in patients receiving caspofungin.",
keywords = "Adverse drug event, Caspofungin, Toxic epidermal necrolysis",
author = "Lee, {Ming Chia} and Ni, {Ya Wen} and Wang, {Chun Hua} and Lee, {Chih Hsin} and Wu, {Ta Wei}",
year = "2010",
month = "6",
doi = "10.1345/aph.1P053",
language = "English",
volume = "44",
pages = "1116--1118",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "6",

}

TY - JOUR

T1 - Caspofungin-induced severe toxic epidermal necrolysis

AU - Lee, Ming Chia

AU - Ni, Ya Wen

AU - Wang, Chun Hua

AU - Lee, Chih Hsin

AU - Wu, Ta Wei

PY - 2010/6

Y1 - 2010/6

N2 - OBJECTIVE: To report a case of suspected caspofungin-induced toxic epidermal necrolysis (TEN). CASE SUMMARY: An 86-year-old man had a right femur intertrochanteric fracture and right proximal humerus fracture due to an accidental fall. Disseminated Candida krusei infection complicated the postoperative course. Candidemia persisted despite 25 days of treatment with parenteral fluconazole. The antifungal agent was changed to intravenous caspofungin. Immediately after administration of a caspofungin 70-mg loading dose, a transient skin rash developed, which resolved after discontinuation of the drug and immediate treatment with intravenous diphenhydramine 30 mg and methylprednisolone 40 mg. Six days later, a caspofungin 70-mg loading dose was given again due to increasing sepsis. Erythematous and purpuric macules and plaques developed the next day and rapidly progressed to extensive erythema, exfoliation, blisters, and skin erosions. A dermatologist was consulted and TEN was diagnosed. The patient was treated with intravenous hydrocortisone 100 mg every 8 hours and diphenhydramine 30 mg every 8 hours. The skin lesions progressed unrelentingly and the patient died of refractory shock 6 days later. DISCUSSION: TEN is a rare but life-threatening systemic and cutaneous disease that is most often the result of an adverse drug reaction. It usually manifests as fever and influenza-like symptoms 1-3 days before the development of mucocutaneous lesions, namely erythema and erosions of the buccal, ocular, and genital mucosa and characteristic epidermal detachment. The precise pathogenesis is not fully understood. Several models have been described, including immunopathology, genetic susceptibility, Fas-Fas ligand, perforin/granzyme, and cytokine dysregulation. Use of the Naranjo probability scale indicated a probable relationship between caspofungin and the development of TEN in this patient. CONCLUSIONS: This is the first report of caspofungin-induced TEN. Health-care professionals are advised to be aware of the early presentations of TEN in patients receiving caspofungin.

AB - OBJECTIVE: To report a case of suspected caspofungin-induced toxic epidermal necrolysis (TEN). CASE SUMMARY: An 86-year-old man had a right femur intertrochanteric fracture and right proximal humerus fracture due to an accidental fall. Disseminated Candida krusei infection complicated the postoperative course. Candidemia persisted despite 25 days of treatment with parenteral fluconazole. The antifungal agent was changed to intravenous caspofungin. Immediately after administration of a caspofungin 70-mg loading dose, a transient skin rash developed, which resolved after discontinuation of the drug and immediate treatment with intravenous diphenhydramine 30 mg and methylprednisolone 40 mg. Six days later, a caspofungin 70-mg loading dose was given again due to increasing sepsis. Erythematous and purpuric macules and plaques developed the next day and rapidly progressed to extensive erythema, exfoliation, blisters, and skin erosions. A dermatologist was consulted and TEN was diagnosed. The patient was treated with intravenous hydrocortisone 100 mg every 8 hours and diphenhydramine 30 mg every 8 hours. The skin lesions progressed unrelentingly and the patient died of refractory shock 6 days later. DISCUSSION: TEN is a rare but life-threatening systemic and cutaneous disease that is most often the result of an adverse drug reaction. It usually manifests as fever and influenza-like symptoms 1-3 days before the development of mucocutaneous lesions, namely erythema and erosions of the buccal, ocular, and genital mucosa and characteristic epidermal detachment. The precise pathogenesis is not fully understood. Several models have been described, including immunopathology, genetic susceptibility, Fas-Fas ligand, perforin/granzyme, and cytokine dysregulation. Use of the Naranjo probability scale indicated a probable relationship between caspofungin and the development of TEN in this patient. CONCLUSIONS: This is the first report of caspofungin-induced TEN. Health-care professionals are advised to be aware of the early presentations of TEN in patients receiving caspofungin.

KW - Adverse drug event

KW - Caspofungin

KW - Toxic epidermal necrolysis

UR - http://www.scopus.com/inward/record.url?scp=77952925853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952925853&partnerID=8YFLogxK

U2 - 10.1345/aph.1P053

DO - 10.1345/aph.1P053

M3 - Article

VL - 44

SP - 1116

EP - 1118

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 6

ER -